Skip to main content

ciclesonide (Alvesco®)

 

Status: Medicine does not meet criteria for AWMSG assessment

Excluded from appraisal by AWMSG as meets exclusion criteria 1. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information.

Medicine details

Medicine name ciclesonide (Alvesco®)
Formulation 80 micrograms and 160 micrograms inhaler
Reference number 85
Indication

Treatment to control persistent asthma in adolescents and adults (aged 12 years and older)

Company Nycomed UK Ltd
BNF chapter Respiratory system
Submission type N/A
Status Medicine does not meet criteria for AWMSG assessment
Date of issue 05/12/2007
Follow AWTTC: